[1]王启平,兰安宁,吴晓峰.低剂量地塞米松对乳腺癌化疗不良反应的影响[J].医学信息,2020,33(14):146-148.[doi:10.3969/j.issn.1006-1959.2020.14.045]
　WANG Qi-ping,LAN An-ning,WU Xiao-feng.Effect of Low-dose Dexamethasone on Adverse Reactions of Chemotherapy in Breast Cancer[J].Medical Information,2020,33(14):146-148.[doi:10.3969/j.issn.1006-1959.2020.14.045]
点击复制

低剂量地塞米松对乳腺癌化疗不良反应的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年14期
页码:
146-148
栏目:
药物与临床
出版日期:
2020-07-15

文章信息/Info

Title:
Effect of Low-dose Dexamethasone on Adverse Reactions of Chemotherapy in Breast Cancer
文章编号:
1006-1959（2020）14-0146-03
作者:
王启平; 兰安宁; 吴晓峰
（大余县人民医院肿瘤科，江西 大余 341500）
Author(s):
WANG Qi-ping; LAN An-ning; WU Xiao-feng
(Department of Oncology,People’s Hospital of Dayu County,Dayu 341500,Jiangxi,China)
关键词:
乳腺癌; 化疗; 地塞米松; 多西他赛
Keywords:
Breast cancer; Chemotherapy; Dexamethasone; Docetaxel
分类号:
R73
DOI:
10.3969/j.issn.1006-1959.2020.14.045
文献标志码:
A
摘要:
目的 探究低剂量地塞米松预处理对乳腺癌术后患者化疗引起的不良反应及生活质量的影响。方法 选取2018年5月~2019年5月我院收治的80例乳腺癌术后化疗患者作为研究对象，按照随机数字表法分为预处理组和非预处理组，各40例。均在术后接受TAC化疗方案，预处理组在化疗前静脉推注地塞米松，非预处理组在化疗前未给予任何干预措施，比较两组化疗后恶心呕吐发生程度、恶心呕吐持续天数、生活质量及安全性。结果 预处理组呕吐、恶心程度低于非预处理组，差异有统计学意义（P＜0.05）；预处理组恶心、呕吐持续天数低于非预处理组[（1.63±0.76）d vs（3.06±1.35）d]、[（0.54±0.19）d vs（1.94±0.63）d]，差异有统计学意义（P＜0.05）；预处理组食欲、精神、睡眠、疲乏、疼痛、对治疗态度、日常生活、治疗副作用、面部表情得分及总分高于非预处理组，差异有统计学意义（P＜0.05）；两组家庭理解与配合、同事的理解与配合、自身对癌症认识得分比较，差异无统计学差异（P＞0.05）。预处理组在化疗前后检查尿常规、大便常规、小便常规、血生化分析、心电图等指标均未发现与激素干预相关的波动。结论 在乳腺癌术后患者化疗前给予小剂量地塞米松预处理，可缓解患者化疗引起的恶心、呕吐等不良反应，提高生活质量，安全有效。
Abstract:
Objective To explore the effect of low-dose dexamethasone pretreatment on adverse reactions and quality of life caused by chemotherapy for breast cancer patients.Methods From May 2018 to May 2019, 80 cases of breast cancer patients undergoing chemotherapy after surgery in our hospital were selected as the research object. They were divided into pretreatment group and non-pretreatment group according to random number table method, 40 cases each. All patients received TAC chemotherapy after surgery. The pretreatment group received intravenous injection of dexamethasone before chemotherapy. The non-pretreatment group did not give any intervention before chemotherapy. Compare the incidence of nausea and vomiting after chemotherapy, the number of days of nausea and vomiting,quality of life and safety.Results The degree of vomiting and nausea in the pretreatment group was lower than that in the non-pretreatment group,the difference was statistically significant(P<0.05); the duration of nausea and vomiting in the pretreatment group was lower than that in the non-pretreatment group [(1.63±0.76) d vs (3.06±1.35) d], [(0.54±0.19) d vs (1.94±0.63) d],the difference was statistically significant (P<0.05); appetite, mental, sleep, fatigue, pain, attitude towards treatment, daily Life, treatment side effects, facial expression score and total score were higher than non-pretreatment group, the difference was statistically significant (P<0.05);There was no significant difference between the two groups in family understanding and cooperation, colleagues’ understanding and cooperation, and their own cancer awareness scores (P>0.05). In the pretreatment group, before and after chemotherapy, the urine routine, stool routine, urine routine, blood biochemical analysis, electrocardiogram and other indicators did not find fluctuations related to hormone intervention.Conclusion Pretreatment with low-dose dexamethasone before breast cancer surgery can relieve nausea and vomiting caused by chemotherapy, improve the quality of life, and be safe and effective.

参考文献/References:

[1]张铁,王丕琳,朱强,等.TAC/AC-T化疗方案对HER-2阴性乳腺癌患者凝血功能的影响[J].肿瘤药学,2019,9(3):427-430.[2]万卉.中西医结合护理改善乳腺癌化疗患者生活质量的临床观察[J].医学信息,2019,32(11):185-187.[3]尹艳芬.穴位贴敷及穴位注射联合低频脉冲治疗肺癌患者化疗所致呕吐的临床观察[J].医学信息,2019,32(23):82-85.[4]李金伟.益气抗癌汤对晚期非小细胞肺癌化疗毒副作用及免疫功能的影响[J].中医药临床杂志,2018,30(10):1886-1888.[5]潘国强,范云.糖皮质激素对免疫检查点抑制剂疗效影响的研究进展[J].中国肺癌杂志,2019,22(12):786-793.[6]Navari Rudolph M.The safety of rolapitant for the treatment of nausea and vomiting associated with chemotherapy[J].Expert Opinion on Drug Safety,2019,18(12):25-29.[7]Ai Z,Gao X,Zheng S,et al.Variability and Influencing Factors of QOL in Breast Cancer Patients Having Chemotherapy[J].Clin Nurs Res,2018:1054773818803691.[8]罗俊波,郑瑞锋,王彦威,等.不同化疗方案在乳腺癌患者术后的应用效果比较[J].河南医学研究,2019,28(4):670-672.[9]Giles AJ,Hutchinson MND,Sonnemann HM,et al.Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy[J]. J Immunother Cancer,2018,6(1):51.[10]Batistaki C,Kaminiotis E,Papadimos T,et al.A Narrative Review of the Evidence on the Efficacy of Dexamethasone on Postoperative Analgesic Consumption[J].Clin J Pain,2017,33(11):1037-1046. [11]滕青华,王延虹,时磊,等.小剂量地塞米松预处理对乳腺癌患者多西紫杉醇化疗致过敏及其他不良反应的影响[J].癌症进展,2019,17(21):2548-2551.[12]王欣.多西他赛不良反应及干预进展[J].中国处方药,2019,17(9):14-15.[13]高雅茹,王玮,袁夏,等.地塞米松降低紫杉醇对肺癌细胞化疗作用的实验研究[J].中国药理学通报,2019,35(3):382-387.[14]任志强,刘丽君,郭利民.大剂量地塞米松的外科实验与临床应用[J].中国医院用药评价与分析,2002,2(4):231-231.[15]Ho CM,Wu HL,Ho ST,et al.Dexamethasone prevents postoperative nausea and vomiting: benefit versus risk[J].Acta Anaesthesiol Taiwan,2011,49(3):100-104.

相似文献/References:

[1]宁尚波,杨东红,付 爽.选择性动脉灌注化疗在口腔癌治疗中的进展[J].医学信息,2018,31(03):28.[doi:10.3969/j.issn.1006-1959.2018.03.009]
　NING Shang-bo,YANG Dong-hong,FU Shuang.Progress of Selective Arterial infusion Chemotherapy in the Treatment of Oral Cancer[J].Medical Information,2018,31(14):28.[doi:10.3969/j.issn.1006-1959.2018.03.009]
[2]董 云.SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
　DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Medical Information,2018,31(14):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[3]李杰萍,姜翠红,管树荣,等.化疗患者PICC置管前后心理体验的质性研究[J].医学信息,2018,31(05):164.[doi:10.3969/j.issn.1006-1959.2018.05.060]
　I Jie-ping,JIANG Cui-hong,GUAN Shu-rong,et al.Qualitative Study of Psychological Experience before and after PICC Catheterization in Patients undergoing Chemotherapy[J].Medical Information,2018,31(14):164.[doi:10.3969/j.issn.1006-1959.2018.05.060]
[4]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
　ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Medical Information,2022,35(14):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[5]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[6]庞小坤,韩 梅,江心灿,等.当归补血汤治疗肿瘤化疗不良反应随机对照临床试验的Meta分析[J].医学信息,2019,32(02):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
　Pang Xiao-kun,Han Mei,Jiang Xin-can,et al.Meta-analysis of a Randomized Controlled Clinical Trial of Angelica Buxue Decoction in the Treatment of Adverse Reactions to Chemotherapy[J].Medical Information,2019,32(14):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
[7]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
　YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Medical Information,2018,31(14):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[8]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
　LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Medical Information,2022,35(14):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[9]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
　LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Medical Information,2019,32(14):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[10]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
　MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Medical Information,2019,32(14):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[11]万 卉.中西医结合护理改善乳腺癌化疗患者生活质量的临床观察[J].医学信息,2019,32(11):185.[doi:10.3969/j.issn.1006-1959.2019.11.058]
　WAN Hui.Clinical Observation on Integrating Traditional Chinese Medicine with Western Medicine to Improve the Quality of Life of Patients with Breast Cancer Chemotherapy[J].Medical Information,2019,32(14):185.[doi:10.3969/j.issn.1006-1959.2019.11.058]
[12]张骁燕.植入式输液港与PICC置管应用于乳腺癌术后化疗的优势[J].医学信息,2019,32(21):184.[doi:10.3969/j.issn.1006-1959.2019.21.063]
　ZHANG Xiao-yan.Implantable Infusion Port and PICC Catheter for the Advantages of Postoperative Chemotherapy for Breast Cancer[J].Medical Information,2019,32(14):184.[doi:10.3969/j.issn.1006-1959.2019.21.063]
[13]王秀秀.认知行为疗法联合睡眠护理模式对乳腺癌术后化疗患者的影响研究[J].医学信息,2022,35(13):183.[doi:10.3969/j.issn.1006-1959.2022.13.046]
　WANG Xiu-xiu.Effect of Cognitive Behavioral Therapy Combined with Sleep Nursing Mode on Postoperative Chemotherapy in Patients with Breast Cancer[J].Medical Information,2022,35(14):183.[doi:10.3969/j.issn.1006-1959.2022.13.046]

更新日期/Last Update: 1900-01-01